XML 54 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
3. STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2014
Stock-based compensation costs $ 60,901 $ 100,323 $ 241,388 $ 125,675  
Options granted 0        
Unrecognized compensation costs related to options vesting     0    
Aggregate intrinsic value of "in the money" outstanding $ 25,140   16,400    
Aggregate intrinsic value of "in the money" exercisable $ 25,140   $ 11,400    
Investors [Member]          
Common stock sold, shares issued     1,044,776    
Proceeds from sale of stock     $ 700,000    
Warrants [Member]          
Warrants outstanding     3,032,794    
Warrant weighted average exercise price     $ 1.03    
Warrants [Member] | June 2008 [Member]          
Warrant weighted average exercise price     $ 0.98    
Warrants authorized for issuance     517,222    
Warrants [Member] | September 2012 [Member]          
Warrant weighted average exercise price     $ 1.06    
Warrants authorized for issuance     2,293,013    
Warrants [Member] | September 2012-2 [Member]          
Warrant weighted average exercise price     $ 0.83    
Warrants authorized for issuance     222,559    
2011 Plan [Member]          
Shares authorized for issuance under the plan     1,825,000    
Stock options outstanding     1,001,602    
Shares available for future grants     823,398    
2006 Plan [Member]          
Shares authorized for issuance under the plan     139,898    
Stock options outstanding     134,398    
Shares available for future grants     0    
1997 Plan [Member]          
Shares available for future grants     0    
Stock Options [Member]          
Options granted     160,000 714,000  
Stock options outstanding 1,136,000   1,136,000 1,079,079 409,087
Selling, General and Administrative Expenses [Member]          
Stock-based compensation costs $ 42,915 36,257 $ 123,370 $ 107,300  
Cost of Goods Sold [Member]          
Stock-based compensation costs 8,669 34,675 60,680 0  
Research and Development Expenses [Member]          
Stock-based compensation costs $ 9,317 $ 29,391 $ 57,338 $ 18,375